摘要
目的:探究内观疗法联合改良森田疗法对广泛性焦虑障碍患者的疗效。方法:招募136例广泛性焦虑障碍患者,随机分成研究组65例和对照组66例。两组均接受药物治疗和1周的集中内观疗法,研究组在此基础上再进行3周的改良森田疗法。在干预前后对两组患者进行状态-特质焦虑问卷(STAI)、症状自评量表(SCL-90)和简明健康调查量表(SF-36)评估。结果:①干预后研究组的STAI中S-AI(t=-2.1319,P=0.0349)和T-AI(t=-3.5233,P=0.0006)因子评分明显低于对照组,有统计学差异;②干预后研究组在SCL-90中躯体化(t=-2.1670,P=0.0321)、焦虑因子(t=-2.2487,P=0.0262)评分显著低于对照组,有统计学差异;③干预后研究组SF-36中的PF(t=3.1485,P=0.0020)、RP(t=5.6213,P=0.0000)、BP(t=5.6366,P=0.0000)、GH(t=2.8269,P=0.0055)、VT(t=5.0271,P=0.0000)、SF(t=8.1617,P=0.0000)、RE(t=19.0254,P=0.0000)和MH(t=7.2255,P=0.0000)因子评分均显著高于对照组,有统计学差异。结论:内观疗法联合改良森田疗法治疗广泛性焦虑障碍的疗效优于单用内观疗法。
Objective:To explore the efficacy of Naikan therapy combined with modified Morita therapy in patients with generalized anxiety disorder.Methods:A total of 136 patients with generalized anxiety disorder were enrolled and randomly divided into study group 65 patients and control group 66 patients completed.Both groups received medical treatment and 1 week of concentrated Naikan therapy,and on the basis of this,the study group was conducting a three-week modified Morita therapy.The State-Trait Anxiety Inventory(STAI),the Symptom Checklist 90(SCL-90),and the 36-Item Short-Form Health Survey(SF-36)were evaluated before and after intervention.Results:① The scores of S-AI(t=-2.1319,P<0.05) and T-AI(t=-3.5233,P<0.01)in STAI of the study group were significantly lower than those of the control group after intervention;②The scores of somatization(t=-2.1670,P<0.05)and anxiety(t=-2.2487,P<0.05)factor of SCL-90 in the study group were significantly lower than those in the control group after intervention;③The scores of PF,RP,BP,GH,VT,SF,RE and MH of SF-36 in the study group were significantly higher than those in the control group after intervention(t=3.1485,5.6213,5.6366,2.8269,5.0271,8.1617,19.0254,7.2255;P<0.01).Conclusion:The efficacy of Naikan therapy combined with modified Morita therapy in the treatment of the patients with generalized anxiety disorder is superior to single Naikan therapy.
引文
[1]刘锡英,王任昌.延续性自我管理教育对广泛性焦虑症患者服药依从性的影响[J].中国健康心理学杂志,2018,26(8):1126-1129
[2]Katzman M A.Current considerations in the treatment of generalized anxiety disorder[J].CNS Drugs,2009,23:103-120
[3]徐海婷,李惠,肖泽萍.广泛性焦虑障碍药物和心理治疗的研究进展[J].临床精神医学杂志,2013,23(3):207-209
[4]王凯.国内认知行为疗法联合药物治疗广泛性焦虑疗效的元分析[J].中国健康心理学杂志,2017,25(4):481-485
[5]詹潮勇,张鸿飞,刘昱君,等.合理情绪疗法对广泛性焦虑障碍药物治疗效果的影响[J].中国健康心理学杂志,2015,23(7):961-963
[6]孙正海,李荐中,王文林,等.广泛性焦虑症心理与药物治疗效果研究[J].中国健康心理学杂志,2010,18(3):272-274
[7]陶金花,王红欣.内观疗法与森田疗法的比较[J].医学与哲学(人文社会医学版),2006,27(10):54+69
[8]毛富强.内观认知疗法应用研究进展[J].中国健康心理学杂志,2014,22(2):316-321
[9]李逢战,路惠捷,杨群,等.森田心理疗法在我国的本土化应用[J].中国医药导报,2017,14(24):54-57
[10]李振涛.森田式心理疗法[J].中华行为医学与脑科学杂志,2014,23(9):851-852
[11]张明园,何燕玲.精神科评定量表手册[M].长沙:湖南科学技术出版社,2015:183-187
[12]汪向东,王希林,马弘.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999:31-35
[13]王玉凤,商敏,关淑芬,等.老年肺癌患者服用吉非替尼期间SF-36生活质量问卷评分的意义[J].中国老年学杂志,2015,35(9):2516-2519
[14]川原隆造,贯名秀,王红欣.内观疗法[J].临床精神医学,2000(增刊):251-255
[15]叶建国,陈军,史琼,等.森田疗法与认知行为疗法的比较分析[J].医学与哲学(人文社会医学版),2007,28(5):60-61
[16]张勤峰,路英智.森田疗法和内观疗法整合用于神经症的理论及实践[J].中国民康医学,2014,26(9):92-93
[17]张永艳,赵景新,王秀梅,等.药物联合改良式森田疗法及内观疗法治疗慢性精神分裂症的临床疗效[J].国际精神病学杂志,2016,43(6):999-1001+1010
[18]倪志强,孙玉红,方艳秋,等.内观疗法联合改良森田疗法对老年癌痛患者创伤后成长的干预效果[J].中华老年医学杂志,2018,37(2):197-201
[19]李雪艳,徐莎,张丽.内观疗法联合森田疗法治疗伴功能性躯体症状抑郁症的疗效观察[J].中国民康医学,2017,29(23):21-23